Anas Ahmad

2.9k total citations · 1 hit paper
69 papers, 2.0k citations indexed

About

Anas Ahmad is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Anas Ahmad has authored 69 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Biomaterials and 12 papers in Pharmaceutical Science. Recurrent topics in Anas Ahmad's work include Nanoparticle-Based Drug Delivery (16 papers), Inflammatory Bowel Disease (10 papers) and Advanced Drug Delivery Systems (9 papers). Anas Ahmad is often cited by papers focused on Nanoparticle-Based Drug Delivery (16 papers), Inflammatory Bowel Disease (10 papers) and Advanced Drug Delivery Systems (9 papers). Anas Ahmad collaborates with scholars based in India, Saudi Arabia and Canada. Anas Ahmad's co-authors include Rehan Khan, Haseeb Ahsan, Ajay Kumar, Syed Shadab Raza, Akshay Vyawahare, Mohammad Imran, Md. Meraj Ansari, Rakesh K. Mishra, Rakesh Kumar Mishra and Muneeb U. Rehman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Journal of Hazardous Materials.

In The Last Decade

Anas Ahmad

66 papers receiving 2.0k citations

Hit Papers

Biomarkers as Biomedical Bioindicators: Approaches and Te... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anas Ahmad India 22 632 386 360 197 189 69 2.0k
Shivkanya Fuloria Malaysia 30 853 1.3× 223 0.6× 270 0.8× 137 0.7× 228 1.2× 130 2.8k
Bang‐Le Zhang China 29 1.1k 1.8× 466 1.2× 440 1.2× 164 0.8× 235 1.2× 111 2.6k
Xuefeng Hou China 25 700 1.1× 428 1.1× 492 1.4× 153 0.8× 153 0.8× 74 1.9k
Bhupinder Kapoor India 25 540 0.9× 296 0.8× 326 0.9× 108 0.5× 121 0.6× 91 2.2k
Abdulmalik Saleh Alfawaz Altamimi Saudi Arabia 32 1.4k 2.2× 418 1.1× 431 1.2× 285 1.4× 128 0.7× 165 3.3k
M. Yasmin Begum Saudi Arabia 22 396 0.6× 286 0.7× 266 0.7× 231 1.2× 123 0.7× 102 1.5k
Yuling Liu China 30 1.0k 1.6× 479 1.2× 387 1.1× 140 0.7× 97 0.5× 112 2.6k
Maged W. Helmy Egypt 33 970 1.5× 792 2.1× 464 1.3× 195 1.0× 94 0.5× 104 2.8k
Ling Zhao China 32 1.0k 1.6× 659 1.7× 472 1.3× 136 0.7× 134 0.7× 95 2.7k
Khalid Saad Alharbi Saudi Arabia 29 1.0k 1.6× 385 1.0× 327 0.9× 107 0.5× 97 0.5× 141 2.7k

Countries citing papers authored by Anas Ahmad

Since Specialization
Citations

This map shows the geographic impact of Anas Ahmad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anas Ahmad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anas Ahmad more than expected).

Fields of papers citing papers by Anas Ahmad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anas Ahmad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anas Ahmad. The network helps show where Anas Ahmad may publish in the future.

Co-authorship network of co-authors of Anas Ahmad

This figure shows the co-authorship network connecting the top 25 collaborators of Anas Ahmad. A scholar is included among the top collaborators of Anas Ahmad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anas Ahmad. Anas Ahmad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kumar, Ajay, Rahul Sakla, Kanika Kanika, et al.. (2025). Engineered Drug-Amphiphile Conjugate Nanoparticles for Targeted Inhibition of AQP4-Mediated NLRP3 Inflammasome Signaling in Collagen-Induced Rheumatoid Arthritis. ACS Applied Materials & Interfaces. 17(11). 16590–16601. 1 indexed citations
3.
4.
Ahmad, Anas, et al.. (2024). Risk Management Compliance of Financial Technology Firms Operating in Jordan. Journal of Logistics Informatics and Service Science. 11(2). 1 indexed citations
5.
Sakla, Rahul, Ajay Kumar, Md. Meraj Ansari, et al.. (2024). Sinapic acid-pullulan based inflammation responsive nanomicelles for the local treatment of experimental inflammatory arthritis. International Journal of Biological Macromolecules. 278(Pt 3). 134903–134903. 5 indexed citations
6.
Ahmad, Anas, Ajay Kumar, Rahul Sakla, et al.. (2024). Leveraging thiol-functionalized biomucoadhesive hybrid nanoliposome for local therapy of ulcerative colitis. Biomaterials. 312. 122747–122747. 11 indexed citations
7.
Ahmad, Anas, Ajay Kumar, Mohammad Fareed, et al.. (2024). Therapeutic cargo-free linalool-based nanoparticles attenuate inflammation by targeting NLRP3 inflammasome. Colloids and Surfaces A Physicochemical and Engineering Aspects. 697. 134337–134337. 6 indexed citations
8.
Ahmad, Anas, et al.. (2024). Review on cerebral malaria—Pathogenesis and role of EphA2 receptor in maintaining blood brain barrier integrity. SHILAP Revista de lepidopterología. 11. 100175–100175. 1 indexed citations
10.
Ahmad, Anas, Summya Rashid, Anis Ahmad Chaudhary, et al.. (2023). Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors. Seminars in Cancer Biology. 89. 38–60. 23 indexed citations
11.
Ahmad, Anas, et al.. (2023). Field based performance evaluation of optimized improved biomass mud cookstoves in rural India. Renewable Energy. 219. 119567–119567. 4 indexed citations
12.
Ahmad, Anas, Mohammad Imran, & Haseeb Ahsan. (2023). Biomarkers as Biomedical Bioindicators: Approaches and Techniques for the Detection, Analysis, and Validation of Novel Biomarkers of Diseases. Pharmaceutics. 15(6). 1630–1630. 127 indexed citations breakdown →
13.
Khan, Rehan, et al.. (2023). α-Terpineol Mitigates Dextran Sulfate Sodium-Induced Colitis in Rats by Attenuating Inflammation and Apoptosis. ACS Omega. 8(32). 29794–29802. 12 indexed citations
14.
Mishra, Rakesh K., Anas Ahmad, Ajay Kumar, et al.. (2023). Cortisone-loaded stearoyl ascorbic acid based nanostructured lipid carriers alleviate inflammatory changes in DSS-induced colitis. Biomaterials Advances. 148. 213383–213383. 18 indexed citations
15.
Ahmad, Anas. (2022). Safety and Toxicity Implications of Multifunctional Drug Delivery Nanocarriers on Reproductive Systems In Vitro and In Vivo. SHILAP Revista de lepidopterología. 4. 895667–895667. 21 indexed citations
16.
Rehman, Muneeb U., Rehan Khan, Andleeb Khan, et al.. (2021). Fate of arsenic in living systems: Implications for sustainable and safe food chains. Journal of Hazardous Materials. 417. 126050–126050. 112 indexed citations
17.
Mishra, Rakesh Kumar, Anas Ahmad, Akshay Vyawahare, et al.. (2021). Biological effects of formation of protein corona onto nanoparticles. International Journal of Biological Macromolecules. 175. 1–18. 68 indexed citations
18.
Ahmad, Anas, Rakesh K. Mishra, Akshay Vyawahare, et al.. (2019). Thymoquinone (2-Isopropyl-5-methyl-1, 4-benzoquinone) as a chemopreventive/anticancer agent: Chemistry and biological effects. Saudi Pharmaceutical Journal. 27(8). 1113–1126. 114 indexed citations
19.
Khan, Rehan, A. Gupta, Anas Ahmad, & Govindasamy Jayamurugan. (2018). Nanoparticle mediated LCS-1 delivery for the targeted therapy of BLM-deficient colorectal cancer cells. 1 indexed citations
20.
Dubey, Ravindra Dhar, et al.. (2010). A New Profile of Therapeutic Potential and Toxicities of Antineoplastic Drugs. Research Journal of Pharmacology and Pharmacodynamics. 2(6). 370–375.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026